PFG
AVXL icon

Prosperity Financial Group’s Anavex Life Sciences AVXL Stock Holding History

Prosperity Financial Group’s Portfolio AVXL Stock Details AVXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-2,600
Closed -$27.9K – 166
2024
Q4 		$27.9K Buy
+2,600
New +$20K 0.01% 169

Other funds holding AVXL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
NL
NWAM LLC Mercer Island, Washington $2B AUM 34.81% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Prosperity Financial Group's AVXL Position: Q1 2025 in Review

Prosperity Financial Group sold out of Anavex Life Sciences (AVXL) in Q1 2025, closing a stake of 7,800 shares — an estimated $83.8K sold.

Prosperity Financial Group first reported a position in AVXL in Q4 2022 and held it in 4 quarters. The position peaked at $444K in Q4 2022. 181 funds tracked by Wall St. Rank hold AVXL as of Q1 2025.

  • Prosperity Financial Group reported no remaining Anavex Life Sciences position as of Q1 2025 after selling out during the quarter.
  • Prosperity Financial Group sold 7,800 Anavex Life Sciences shares in Q1 2025, an estimated $83.8K.
  • Prosperity Financial Group first reported a position in Anavex Life Sciences in Q4 2022 and held it in 4 quarters.
  • Prosperity Financial Group's Anavex Life Sciences position peaked at $444K in Q4 2022.
  • 181 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q1 2025.

Based on Prosperity Financial Group's 13F filing for Q1 2025, filed 15 May 2025.